SFZN.SW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 08:03):

Stats
Today's Volume	866.00
Average Volume	6 818.00
Market Cap	3.75B
EPS	CHF0 ( 2024-02-19 )
Last Dividend	CHF0 ( N/A )
Next Dividend	CHF0 ( N/A )
P/E	33.36
ATR14	CHF1.081 (0.12%)

Volume Correlation

Long: 0.10 (neutral)

Short: 0.19 (neutral)

Signal:(57.568) Neutral

Siegfried Holding AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Siegfried Holding AG Correlation - Currency/Commodity

0.76
( moderate )

0.77
( moderate )

-0.88
( strong negative )

0.75
( moderate )

-0.65
( weak negative )

-0.25
( neutral )

Siegfried Holding AG Financials

Annual	2023
Revenue:	CHF1.27B
Gross Profit:	CHF320.41M (25.20 %)
EPS:	CHF26.61

Q4	2023
Revenue:	CHF664.44M
Gross Profit:	CHF172.72M (26.00 %)
EPS:	CHF13.23

Q2	2023
Revenue:	CHF607.05M
Gross Profit:	CHF147.69M (24.33 %)
EPS:	CHF12.99

Q4	2022
Revenue:	CHF642.78M
Gross Profit:	CHF162.50M (25.28 %)
EPS:	CHF21.77

Financial Reports:

No articles found.

Siegfried Holding AG

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.